SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $177,878,251 |
| Positions | 10 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| INNOVIVA INC | INVA | COM | $42,935,617 | 1,890,604 |
| IRONWOOD PHARMACEUTICALS INC | IRWD | COM CL A | $38,684,153 | 9,188,635 |
| AMARIN CORP PLC | AMRN | SPONSORED ADR | $26,673,916 | 1,673,395 |
| NEUROCRINE BIOSCIENCES INC | NBIX | COM | $19,639,889 | 116,533 |
| CYTOKINETICS INC | CYTK | COM NEW | $19,476,393 | 228,623 |
| LANTHEUS HLDGS INC | LNTH | COM | $18,517,994 | 166,919 |
| BIOHAVEN LTD | BHVN | COM | $8,664,803 | 582,312 |
| REGENERON PHARMACEUTICALS | REGN | COM | $2,612,633 | 4,190 |
| VOR BIOPHARMA INC | VOR | COM NEW | $467,596 | 25,399 |
| BIOGEN INC | BIIB | COM | $205,257 | 950 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.